Pixyl
La Tronche
About Pixyl
Pixyl’s neuroimaging cloud platform facilitates data-driven and value-based patient care by making decision-critical neuroimaging information accessible to clinicians, when it matters. We deliver automatic neuroimaging biomarker extraction for improved insight and decision-making in clinical studies and routine clinical practice. Our cloud-based solutions are designed for seamless integration into the workflows of imaging CROs, neuroradiologists and neurologists. Our platform, Pixyl.Neuro, leverages advanced machine learning methods to deliver quantitative measures of brain atrophy and/or lesion quantification and classification for MS, Stroke, and neurodegenerative diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.3M
- Funding stage: M&A
- Last round: Series Unknown (Apr 2021)
- Website: pixyl.ai
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Health Care, Machine Learning, Medical Device, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/pixyl-138216 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.